User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 7 results.
    • Journal article
    Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
    Haioun, C. Besson, C Lepage, E. Thieblemont, C Simon, D Rose, C Tilly, H. Sonet, Anne Lederlin, P. Attal, M. Briere, J Reyes, F. (2000) Annals of Oncology — Vol. 11, no. 6, p. 685-690 (2000)
    • Speech
    Rituximab given after high dose therapy and autologous stem cell transplantation induces durable clearance of minimal residual disease in about half of the patients with follicular non Hodgkin's lymphoma: 36 months results of a multicenter open label phase II trial (M39012 trial).
    Morschhauser, F. Recher, C. Milpied, N. Gressin, R Salles, G. Brice, P. Vey, N Haioun, C. Colombat, P Bourhis, JH Rossi, JF Berriot-Varoqueaux, N Bergougnoux, L Bosly, André[UCL] Delsol, G. Attal, M. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma
    Harousseau, J. L. Avet-Loiseau, H. Mary, J. Facon, T. Attal, M. Doyen, Chantal[UCL] Hulin, C. Garderet, L. Tiab, M. Lepeu, G. Araujo, C. Caillot, D. Petillon, M. Mathiot, C. Moreau, P. (2010) 15th Annual Meeting of the European-Hematology-Association — Barcelona(Spain)
    • Journal article
    Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
    Tilly, H. Lepage, E. Coiffier, B. Blanc, M. Herbrecht, R. Bosly, André[UCL] Attal, M. Fillet, G. Guettier, C. Molina, TJ Gisselbrecht, C. Reyes, F. (2003) Blood — Vol. 102, no. 13, p. 4284-4289 (2003)
    • Speech
    High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma
    Haioun, C. Lepage, E. Gisselbrecht, C. Coiffier, B. Doyen, Chantal Morel, Priscilla[UCL] Attal, M. Tilly, H. Deconinck, E Gaulard, P. Reyes, F. (1998) International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Diffuse Large-Cell Lymphoma — LYON(France)
    • Journal article
    Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: A study from the European Group for Blood and Marrow Transplantation (EBMT)
    Jantunen, E. Canals, C. Attal, M. Thomson, K. Milpied, N. Buzyn, A. Ferrant, Augustin[UCL] Biron, P. Crawley, C. Schattenberg, A. Luan, J.J. Tilly, H. Rio, B. Wijermans, P.W. Dreger, P. Sureda, A. (2012) Annals of Oncology — Vol. 23, no. 1, p. 166-171 (2012)
    • Journal article
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
    Moreau, P. Attal, M. Garban, F. Hulin, C. Facon, T. Marit, G. Michallet, M. Doyen, Chantal[UCL] Leyvraz, S. Mohty, M. Wetterwald, M. Mathiot, C. Caillot, D. Berthou, C. Benboubker, L. Garderet, L. Chaleteix, C. Traullé, C. Fuzibet, J. G. Jaubert, J. Lamy, T. Casassus, P. Dib, M. Kolb, B. Dorvaux, V. Grosbois, B. Yakoub-Agha, I. Harousseau, J. L. Avet-Loiseau, H. SAKK IFM Group (2007) Leukemia — Vol. 21, no.9, p. 2020-2024 (2007)